Font Size


Public Health Dynamics Seminars

Monday, March 12 - Policy Modeling at the Intersection of Drug and Infectious Disease Epidemics

Jeremy Goldhaber-Fiebert, PhD

Associate Professor of Medicine
Core Faculty Member
Centers for Health Policy/Primary Care and Outcomes Research
Stanford University

Monday, March 12, 2018
12:00 – 1:00 PM
Public Health 1149 (New Location)


In the United States, worrisome shifts and upsurges in the epidemiology of HIV and hepatitis C virus (HCV) are thought to be driven by shifting patterns of risk behaviors, both in terms of injection drug use and sexual behaviors. Increased incidence has occurred in subgroups defined in terms of age, sex, risk behaviors, and geography. Proposed policies to address such threats frequently involve targeting specific subgroups and the use of multiple, simultaneous interventions. Dr. Goldhaber-Fiebert describe the development, calibration, and validation of a microsimulation model which captures injection and non-injection use of opioids and stimulants; heterosexual, homosexual, and bisexual age-specific mixing; and HIV, HCV, and co-infection to represent various geographic settings in the United States. He then uses the model to illustrate the multiple effects of various interventions that target specific diseases and/or risk behaviors (e.g., expanding HCV treatment for people who inject drugs, directly administered antiretroviral therapy, syringe services programs).

About the speaker:

Jeremy Goldhaber-Fiebert, PhDJeremy Goldhaber-Fiebert, PhD, is an Associate Professor of Medicine and a Core Faculty Member at the Centers for Health Policy/Primary Care and Outcomes Research. His research focuses on complex policy decisions surrounding the prevention and management of increasingly common, chronic diseases and the life course impact of exposure to their risk factors. In the context of both developing and developed countries including the US, India, China, and South Africa, he has examined chronic conditions including type 2 diabetes and cardiovascular diseases, human papillomavirus and cervical cancer, tuberculosis, HIV, and hepatitis C and on risk factors including smoking, physical activity, obesity, malnutrition, and other diseases themselves. He combines simulation modeling methods and cost-effectiveness analyses with econometric approaches and behavioral economic studies to address these issues. His current work also considers the value of conducting additional research and specifically optimal study designs as medical care is increasingly personalized. Dr. Goldhaber-Fiebert graduated magna cum laude from Harvard College in 1997, with an A.B. in the History and Literature of America. After working as a software engineer and consultant, he conducted a year-long public health research program in Costa Rica with his wife in 2001. Winner of the Lee B. Lusted Prize for Outstanding Student Research from the Society for Medical Decision Making in 2006 and in 2008, he completed his PhD in Health Policy concentrating in Decision Science at Harvard University in 2008. He was elected as a Trustee of the Society for Medical Decision Making in 2011.








You are here: Home Seminar Series 2017 - 2018 Monday, March 12 - Policy Modeling at the Intersection of Drug and Infectious Disease Epidemics